📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-04 17:15
510 analysed today
510
Today
133,399
All-time analysed
40,108
Positive
6,279
Negative
79,197
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
29 announcements match the current filters (relevance ≥ 5).
HUL Q1 FY27: 10% Revenue Growth Driven by 5% Volume Recovery; EBITDA Margin at 23%
Hindustan Unilever (HUL) reported a strong start to FY27 with revenue growing 10% YoY to ₹17,184 crores, its highest growth in 13 quarters. This growth was balanced, with 5% coming from volume and 5% from pricing, a significant step-up from the 3% growth seen in H1 FY26. The company maintained an EBITDA margin of 23% while aggressively increasing its advertising and promotion (A&P) spends to ₹1,657 crores, the highest in 11 quarters. Management highlighted market share gains in 85% of segments and strong double-digit growth in quick commerce and digital-first brands like Minimalist.
Confidence: HIGH
What changedHUL has accelerated from low single-digit growth to double-digit growth (10%) with a healthy 5% volume contribution, marking a turnaround from previous quarters.
Why it mattersThe recovery in volume growth and market share gains suggests HUL's premiumization and digital-first strategies are offsetting rural and inflationary pressures.
Quarterly Revenue: ₹17,184 croresUnderlying Volume Growth: 5%EBITDA Margin: 23%A&P Spend: ₹1,657 croresRevenue vs TTM Revenue: 26.21%
📅 Short termThe stock may see positive sentiment as the 10% growth exceeds recent trends and volume growth has finally hit the 5% mark.
📈 Long termStructural improvements through the Ice Cream demerger and expansion into high-growth categories like Bodywash and Digital-first brands support long-term compounding.
⚠ Risk flags
- Volatility in crude oil prices impacting Home Care margins
- Inflationary trends in tea procurement
- Geopolitical tensions affecting global supply chains
Key Highlights
Revenue grew 10% YoY to ₹17,184 crores, representing ~26% of TTM revenue.
Underlying Volume Growth (UVG) improved to 5%, showing a recovery in consumer demand.
A&P spends reached an 11-quarter high of ₹1,657 crores to support brand building and innovation.
Adjusted Profit After Tax (PAT) grew 11% YoY, excluding one-off credits from the previous year.
Ice Cream demerger is expected to provide a structural EBITDA margin uplift of 50-60 bps.
👀 What to Watch
Monitor the upcoming Capital Markets Day in September 2026 for detailed strategy updates. Investors should also track the impact of tea and crude oil price volatility on margins in the coming quarters.
10% Sales Growth: HUL Reports Highest Growth in 13 Quarters for JQ'26
Hindustan Unilever (HUL) reported a strong start to FY27 with a 10% increase in turnover to ₹17,184 crores, driven by 5% underlying volume growth. The Home Care segment led performance with 14% growth, its highest in three years, while Beauty & Wellbeing grew 12%. EBITDA rose 8% to ₹3,947 crores, though margins contracted slightly by 40 bps to 23.0% due to commodity volatility. Reported PAT saw a marginal 2% decline to ₹2,680 crores, primarily due to a high base effect from a one-off tax credit in the previous year.
Confidence: HIGH
What changedHUL has accelerated from low-single-digit growth in previous quarters to double-digit sales growth (10%) and 5% volume growth in JQ'26.
Why it mattersThe results signal a recovery in FMCG demand and the success of HUL's premiumization strategy, particularly in Home Care and Beauty segments which are key margin drivers.
Quarterly Turnover: ₹17,184 crTurnover vs TTM Revenue: ~26.2%Underlying Volume Growth: 5%EBITDA Margin: 23.0%PAT (before exceptional items): ₹2,731 cr
📅 Short termThe stock may see positive momentum as the 10% sales growth exceeds recent historical trends and volume growth remains healthy.
📈 Long termHUL's focus on premiumization and digital transformation (AI-enabled distribution) positions it well to capture long-term consumption growth in India.
⚠ Risk flags
- Persistent palm oil inflation impacting Skin Cleansing margins
- Geopolitical volatility affecting global commodity prices
- Transition risks in the OZiva business
Key Highlights
Delivered 10% Underlying Sales Growth (USG), the highest in 13 quarters.
Underlying Volume Growth (UVG) stood at 5%, indicating a recovery in demand.
Home Care segment revenue reached ₹6,554 crores with a 14% USG.
Boost brand surpassed the ₹1,000 crore annual turnover milestone on a trailing 12-month basis.
EBITDA margin remained within the guided range at 23.0% despite palm oil inflation.
👀 What to Watch
Watch for the impact of palm oil price volatility on the Personal Care segment's margins and the execution of the Ice Cream demerger. Monitor if the 5% volume growth momentum sustains through the festive season.
HINDUNILVR Q1 FY27: Revenue grows 10.3% to ₹17,149 Cr; Net Profit dips 3.2% YoY
Hindustan Unilever (HUL) reported a 10.3% YoY increase in revenue from continuing operations to ₹17,149 Cr for the quarter ended June 2026. However, consolidated net profit for the period declined by 3.2% YoY to ₹2,680 Cr, primarily due to higher total expenses which rose 10% to ₹13,822 Cr. The results reflect the company's transition as the Ice Cream business is now classified under discontinued operations. Advertising and promotion spending remained high at ₹1,657 Cr, representing 9.7% of revenue, as the company continues its strategy of market development and premiumization.
Confidence: HIGH
What changedHUL has officially moved its Ice Cream business to 'discontinued operations' and reported its first set of results for FY27 showing double-digit top-line growth but a slight contraction in profitability.
Why it mattersAs a bellwether for Indian consumption, HUL's 10% revenue growth suggests resilient demand, but the profit dip highlights ongoing margin pressure from input costs and high competitive spending (A&P).
Revenue (Q1 FY27): ₹17,149 CrNet Profit (Q1 FY27): ₹2,680 CrRevenue Growth (YoY): 10.3%Quarterly Revenue vs TTM Revenue: ~26.2%Ad Spend as % of Revenue: 9.7%
📅 Short termThe stock may face mild pressure or trade sideways as the market digests the 3.2% dip in net profit despite the healthy revenue growth.
📈 Long termThe structural shift towards premiumization and the demerger of the lower-margin Ice Cream business are intended to drive margin expansion over the next 2-3 years.
⚠ Risk flags
- Input cost volatility (specifically palm oil spikes)
- Competitive intensity requiring sustained high advertising spend
- Transitory impacts from the Ice Cream business demerger
Key Highlights
Revenue from operations grew 10.3% YoY to ₹17,149 Cr from ₹15,552 Cr in the year-ago quarter.
Net profit from continuing operations decreased by 2.2% to ₹2,680 Cr compared to ₹2,741 Cr in Q1 FY26.
Advertising and promotion expenses increased to ₹1,657 Cr, up from ₹1,598 Cr in the previous year.
Total expenses for the quarter stood at ₹13,822 Cr, a 10% increase over the ₹12,565 Cr reported in Q1 FY26.
Earnings Per Share (EPS) for continuing and discontinued operations combined fell to ₹11.38 from ₹11.73 YoY.
👀 What to Watch
Investors should monitor volume growth figures in the detailed investor presentation to see if the 10.3% revenue growth is volume-led or price-led. Additionally, track the execution timeline of the Ice Cream business demerger, which is expected to improve overall EBITDA margins by 50-60 bps.
HUL Launches Global Fragrance Hub in Mumbai as part of €100M Innovation Programme
Hindustan Unilever Limited (HUL) has inaugurated the Unilever Fragrance Hub (UFH) in Mumbai, marking its third global facility after the UK and US. This hub is part of a larger €100 million global investment programme aimed at enhancing in-house, digitally enabled fragrance creation. Located at the IIT Bombay campus, the facility will utilize AI and advanced science to drive product premiumisation across categories like personal care and home care. This strategic move positions India as a critical R&D engine for Unilever's global operations.
Key Highlights
Establishment of the 3rd global Unilever Fragrance Hub in Mumbai, following locations in the UK and US.
Investment is part of a €100 million global programme to advance digital and AI-driven fragrance innovation.
Strategic colocation at the IIT Bombay campus to facilitate industry-academia collaboration in science and technology.
Focus on accelerating premiumisation and product desirability across FMCG categories like shampoos, body washes, and detergents.
The hub integrates proprietary creation software and advanced compounding technologies for end-to-end fragrance design.
👀 What to Watch
Investors should monitor this as a long-term margin-accretive move, as the hub's focus on premiumisation and AI-driven R&D is likely to enhance HUL's competitive edge and product pricing power. No immediate action is required, but it reinforces HUL's leadership in the high-growth Indian FMCG sector.
HUL 93rd AGM: Final Dividend of ₹22/Share Proposed; Total FY26 Payout at ₹41/Share
Hindustan Unilever Limited (HUL) has scheduled its 93rd Annual General Meeting for June 30, 2026. The company has proposed a final dividend of ₹22 per share, which, along with the ₹19 interim dividend already paid, brings the total dividend for FY 2025-26 to ₹41 per share. Key agenda items include the re-appointment of several directors and the approval of a second five-year term for Independent Director Ashu Suyash. The record date for dividend eligibility is fixed as June 23, 2026.
Key Highlights
Proposed final dividend of ₹22 per equity share of ₹1 each for FY 2025-26.
Total dividend payout for the full financial year 2025-26 reaches ₹41 per share.
AGM to be held on June 30, 2026, with the record date for dividend set for June 23, 2026.
Seeking shareholder approval for re-appointment of directors Nitin Paranjpe, Niranjan Gupta, and B.P. Biddappa.
Special resolution proposed for re-appointment of Ms. Ashu Suyash as Independent Director until November 2031.
👀 What to Watch
Investors seeking the final dividend of ₹22 per share must ensure they hold the stock before the June 23, 2026 record date. No specific action is required regarding the routine director re-appointments unless shareholders have specific governance concerns.
HUL Launches Unilever Fragrance Hub in Mumbai as part of €100 Million Global Program
Hindustan Unilever Limited has inaugurated the Unilever Fragrance Hub in Mumbai, marking the third such global facility after the UK and US. This hub is a key component of Unilever's €100 million global investment program focused on advancing in-house, digitally enabled fragrance creation. Located at the IIT Bombay campus, the facility integrates AI and advanced science to drive product premiumization across categories like home and personal care. The investment aims to leverage Indian consumer insights to design fragrances that can be scaled globally, enhancing HUL's R&D self-reliance.
Key Highlights
Inauguration of the 3rd global Unilever Fragrance Hub in Mumbai, following established hubs in the UK and US.
Part of a larger €100 million global programme to enhance digitally enabled fragrance innovation and R&D.
Strategic colocation at the IIT Bombay campus to facilitate collaboration with academia in data and digital-first science.
Focus on using AI and advanced compounding technologies to accelerate premiumization in shampoos, body washes, and detergents.
Aims to reduce response time and improve self-reliance in fragrance application and evaluation for the Indian market.
👀 What to Watch
Investors should view this as a positive long-term strategic move that strengthens HUL's R&D moat and supports its premiumization strategy. Monitor the company's ability to improve margins in the Personal Care and Home Care segments through these enhanced innovation capabilities.
HUL Q4 FY26: 8% Revenue Growth Driven by 7% USG; Highest Growth in 12 Quarters
Hindustan Unilever (HUL) reported a strong finish to FY26, with Q4 revenue growing 8% and Underlying Sales Growth (USG) at 7%, marking its highest growth in three years. For the full year, turnover reached Rs. 63,763 crores with a 5% USG and 4% volume growth, showing significant acceleration in the second half. The company is aggressively pivoting towards premiumization, with its liquids portfolio crossing Rs. 4,000 crores and Masstige/Wellbeing segments reaching a Rs. 1,200 crore run rate. Despite rising crude costs due to geopolitical tensions, HUL maintained a healthy EBITDA margin of 23.7%.
Key Highlights
Q4 FY26 revenue grew 8% YoY with 7% Underlying Sales Growth (USG), driven primarily by volumes.
Full-year FY26 turnover reached Rs. 63,763 crores with a 4% Underlying Volume Growth (UVG).
Home Care liquids portfolio crossed the Rs. 4,000 crore milestone, while Vaseline surpassed Rs. 1,000 crores.
E-commerce channel grew over 25% during the year, supported by a dedicated Quick Commerce organization.
Committed Rs. 2,000 crores in capex for premium formats in Beauty and Home Care to drive future growth.
👀 What to Watch
Investors should take confidence in the volume-led growth recovery and the successful scaling of premium and digital-first portfolios. Monitor the impact of crude-linked commodity inflation on margins in the near term given the recent geopolitical volatility.
HUL Q4 FY26: Revenue Up 8%, Volume Growth Hits 12-Quarter High of 6%; Rs 22 Final Dividend
Hindustan Unilever (HUL) reported a strong Q4 FY26 with consolidated revenue growing 8% YoY to Rs. 16,207 crores, driven by a 6% underlying volume growth, the highest in 12 quarters. EBITDA margins improved sequentially to 23.7%, while reported PAT surged 20% to Rs. 3,002 crores, aided by a stake divestment in Nutritionalab. For the full year FY26, the company achieved a turnover of Rs. 63,763 crores with a 4% volume growth. The board has proposed a final dividend of Rs. 22 per share, bringing the total FY26 payout to Rs. 41 per share.
Key Highlights
Q4 Revenue grew 8% YoY to Rs. 16,207 crores with a 12-quarter high volume growth (UVG) of 6%.
EBITDA margin improved 40 bps sequentially to 23.7%, with absolute EBITDA up 6% YoY at Rs. 3,841 crores.
Home Care segment delivered 9% growth, while Vaseline and Sunsilk both crossed the Rs. 1,000 crore annual turnover milestone.
Reported PAT for Q4 rose 20% YoY to Rs. 3,002 crores, including proceeds from the divestment of Nutritionalab Pvt. Ltd.
Total dividend for FY26 stands at Rs. 41 per share, including a newly proposed final dividend of Rs. 22.
👀 What to Watch
Investors should take confidence in the recovery of volume growth and sequential margin expansion, which suggests strengthening consumer demand. The stock remains a core defensive holding with a robust dividend yield and market leadership in key categories.
HUL Recommends ₹22 Final Dividend; FY26 Consolidated Turnover Rises to ₹63,763 Crores
Hindustan Unilever Limited (HUL) reported a consolidated turnover of ₹63,763 crores for FY 2025-26, marking a growth from ₹60,573 crores in the previous year. However, consolidated Profit After Tax (PAT) saw a marginal decline to ₹10,652 crores from ₹10,680 crores, impacted by exceptional losses. The Board has recommended a final dividend of ₹22 per share, bringing the total payout for the year to ₹41 per share. The record date for the final dividend entitlement is fixed as June 23, 2026.
Key Highlights
Consolidated turnover for FY26 grew 5.3% year-on-year to ₹63,763 crores.
Consolidated Profit After Tax (PAT) stood at ₹10,652 crores versus ₹10,680 crores in the previous year.
Final dividend of ₹22 per share recommended, taking total FY26 dividend to ₹41 per share.
Exceptional items for the year resulted in a loss of ₹235 crores compared to a gain of ₹347 crores last year.
Record date for the final dividend is set for June 23, 2026.
👀 What to Watch
Investors should focus on the steady revenue growth and consistent dividend yield despite flat bottom-line performance. The stock remains a defensive play, but monitoring margin recovery and volume growth in the investor presentation is advised.
HUL FY26 Revenue Grows 5.3% to ₹63,763 Cr; Total Dividend Declared at ₹41 Per Share
Hindustan Unilever Limited (HUL) reported a 5.26% growth in consolidated turnover to ₹63,763 crores for the financial year ended March 31, 2026. Despite the revenue growth, Consolidated Profit After Tax (PAT) saw a marginal decline to ₹10,652 crores from ₹10,680 crores in the previous year. The bottom line was impacted by an exceptional loss of ₹235 crores compared to a gain of ₹347 crores in FY25. The Board has recommended a final dividend of ₹22 per share, taking the total dividend for the year to ₹41 per share.
Key Highlights
Consolidated turnover increased to ₹63,763 crores in FY26 from ₹60,573 crores in FY25.
Consolidated Profit After Tax (PAT) stood at ₹10,652 crores, a slight decrease from ₹10,680 crores YoY.
Recommended a final dividend of ₹22 per share, with the record date set for June 23, 2026.
Total dividend for FY26 reaches ₹41 per share, including an interim dividend of ₹19 paid earlier.
Exceptional items resulted in a loss of ₹235 crores versus a gain of ₹347 crores in the previous fiscal.
👀 What to Watch
Investors should note the stagnant profit growth despite rising revenues and monitor the impact of exceptional items on the bottom line. The stock remains a steady dividend play with a total payout of ₹41 for the year.
HUL Clarifies No Plans to Divest Foods Portfolio Following Unilever PLC Announcement
Hindustan Unilever Limited (HUL) has issued a formal clarification to the stock exchanges following an announcement by its parent company, Unilever PLC. The company emphasized that the Foods business remains a strategic and attractive segment for its Indian operations. HUL explicitly denied being in any discussions regarding the divestment of its Foods portfolio. This clarification is intended to address market speculation and confirm the stability of its current business structure in India.
Key Highlights
HUL issued a clarification under SEBI Regulation 30 following Unilever PLC's global announcement.
The company confirmed that the Foods segment remains an important and attractive business for HUL.
HUL stated it is not in any discussions regarding the divestment of its Foods portfolio.
The announcement aims to maintain investor confidence amidst global restructuring at the parent level.
👀 What to Watch
Investors should maintain their positions as the core business structure remains intact despite global changes at Unilever PLC. Monitor the Foods segment's growth contribution in upcoming quarterly results to assess its continued strategic value.
HUL Completes Sale of 19.8% Stake in Nutritionalab for INR 307 Crores
Hindustan Unilever Limited (HUL) has successfully concluded the divestment of its entire 19.8% equity interest in Nutritionalab Private Limited. The transaction was finalized for a total cash consideration of approximately INR 307 Crores. This move follows the initial proposal announced on February 12, 2026, and marks a complete exit from the entity. The divestment is part of HUL's ongoing efforts to optimize its portfolio and focus on core business segments.
Key Highlights
Completed the sale of the entire 19.8% shareholding in Nutritionalab Private Limited
Total cash consideration received for the stake sale amounts to approximately INR 307 Crores
The transaction was executed following the initial disclosure made on February 12, 2026
The exit allows the company to reallocate capital towards primary growth drivers
👀 What to Watch
Investors should view this as a positive move towards capital efficiency and portfolio rationalization. While the deal size is small relative to HUL's total market cap, it demonstrates disciplined asset management.
HUL Q3 FY26: 5% Sales Growth and 4% Volume Growth; Reported PAT Surges 121% on One-offs
Hindustan Unilever reported a steady performance for the quarter ended December 31, 2025, with Underlying Sales Growth of 5% and Volume Growth of 4%. Reported Profit After Tax jumped 121% to 6,603 crores, primarily driven by one-off gains from the Ice Cream business demerger and OZiva fair valuation. The company's EBITDA margin remained stable at 23.3%, while the D2C portfolio featuring Minimalist and OZiva reached a combined ARR of 1,100 crores. Management highlighted a recovery in consumer sentiment and significant growth in Quick Commerce, which now accounts for 3% of total sales.
Key Highlights
Underlying Sales Growth (USG) of 5% and Underlying Volume Growth (UVG) of 4% for the quarter.
Reported PAT grew 121% YoY to 6,603 crores, aided by exceptional items from the Ice Cream demerger.
EBITDA margin stood at 23.3% with Gross Margins improving by 30 bps to 50.8%.
Quick Commerce channel is doubling every quarter and now contributes approximately 3% of total revenue.
Minimalist and OZiva brands have achieved a combined Annual Recurring Revenue (ARR) of 1,100 crores.
👀 What to Watch
Investors should monitor the steady volume recovery and the successful scaling of high-margin D2C brands. The structural shift toward Quick Commerce and organizational streamlining suggests a strong focus on agility and premiumization.
HUL to Invest ₹2,000 Crore to Expand Premium Manufacturing Capacity
Hindustan Unilever (HUL) has announced a strategic investment of ₹2,000 crore to be deployed over the next two years. This capital expenditure is focused on expanding manufacturing capacity for high-growth premium categories within Beauty & Wellbeing and Home Care liquids. The initiative aims to modernize the supply chain through automation and digital technologies while targeting 100% renewable energy for the new facilities. This move underscores HUL's commitment to premiumization and scaling high-margin segments to meet evolving consumer demands.
Key Highlights
Proposed investment of ₹2,000 crore over a two-year period across multiple locations.
Focus on premium Skin Care, Hair Care, and Home Care liquid categories.
Capacity expansion to leverage advanced automation and digital technologies for supply-chain agility.
New facilities designed to operate on 100% renewable energy in line with sustainability goals.
👀 What to Watch
Investors should view this as a positive long-term indicator of HUL's focus on high-margin premium segments. Monitor the progress of this capex and its eventual impact on volume growth and operating margins.
HUL Completes Acquisition of Remaining 49% Stake in Zywie Ventures for INR 824 Crores
Hindustan Unilever Limited (HUL) has successfully completed the acquisition of the balance 49% stake in Zywie Ventures Private Limited. The transaction was finalized for a total consideration of INR 824 Crores, following the terms of the Share Subscription and Share Purchase Agreement. This move gives HUL full ownership of the entity, which is known for its health and wellness brand OZiva. The acquisition aligns with HUL's long-term strategy to scale its presence in the high-growth digital-first wellness segment.
Key Highlights
Acquisition of the remaining 49% stake in Zywie Ventures Private Limited completed on February 13, 2026.
Total cash consideration for the final tranche of shares is INR 824 Crores.
Zywie Ventures becomes a wholly-owned subsidiary of Hindustan Unilever Limited.
The transaction was executed in accordance with the Share Subscription and Share Purchase Agreement dated February 12, 2026.
👀 What to Watch
Investors should view this as a positive consolidation of HUL's portfolio in the premium wellness category. Monitor the integration of Zywie's brands and their impact on HUL's overall margin profile in the coming quarters.
HUL Subsidiary Kwality Wall’s (India) to List 234.96 Cr Shares on Feb 16, 2026
Hindustan Unilever Limited (HUL) has announced that its subsidiary/demerged entity, Kwality Wall’s (India) Limited (KWIL), has received final listing and trading approvals from both BSE and NSE. A total of 2,34,95,91,262 equity shares of face value ₹1 each will be admitted to dealings. Trading is scheduled to commence on February 16, 2026, under the symbol 'KWIL' on the NSE. This marks the final stage of the Scheme of Arrangement intended to unlock value for HUL shareholders.
Key Highlights
Listing and trading approval received for 2,34,95,91,262 equity shares of ₹1 each
Trading of KWIL shares to officially commence on February 16, 2026
Approvals received from both BSE (Notice 20260212-18) and NSE (Ref: NSE/LIST/190)
The listing follows a court-approved Scheme of Arrangement between HUL and KWIL
KWIL will trade under the symbol 'KWIL' on the National Stock Exchange
👀 What to Watch
Investors should track the listing price on February 16 to determine the market valuation of the standalone ice cream business. Existing HUL shareholders who were allotted KWIL shares should hold or trade based on their outlook for the frozen desserts sector.
HUL Q3 Net Profit Surges to ₹6,603 Cr Driven by ₹4,516 Cr Exceptional Gain
Hindustan Unilever Limited (HUL) reported a 3% YoY increase in revenue from operations at ₹16,197 crore for the quarter ended December 31, 2025. While total net profit jumped to ₹6,603 crore from ₹2,694 crore YoY, this was primarily due to a massive one-time exceptional gain of ₹4,516 crore from discontinued operations. Profit from continuing operations actually saw a decline, falling to ₹2,118 crore compared to ₹2,791 crore in the year-ago period, reflecting margin pressures.
Key Highlights
Revenue from operations grew 3.06% YoY to ₹16,197 crore from ₹15,715 crore.
Total Net Profit stood at ₹6,603 crore, significantly boosted by a ₹4,516 crore exceptional credit in discontinued operations.
Profit from continuing operations decreased by 24% YoY to ₹2,118 crore.
Advertising and promotion expenses remained high at ₹1,522 crore to maintain market share.
Basic EPS for the quarter rose to ₹28.12 from ₹11.43 YoY, largely due to the one-time gain.
👀 What to Watch
Investors should discount the massive jump in net profit as it is driven by a one-time exceptional item. Focus on the underlying performance of continuing operations, which shows a decline in profitability despite modest revenue growth.
HUL DQ'25 Results: 4% Volume Growth, Reported PAT Surges 121% on Ice Cream Demerger One-offs
Hindustan Unilever Limited (HUL) reported a steady 4% underlying volume growth and 5% underlying sales growth for the quarter ended December 2025, with turnover reaching ₹16,235 crores. While reported PAT jumped 121% to ₹6,603 crores due to one-off gains from the Ice Cream business demerger, normalized PAT (before exceptional items) grew marginally by 1% to ₹2,562 crores. EBITDA margins saw a 70 bps compression to 23.3% as the company continues to invest in premiumization and digital channels. The company is also restructuring into a 'Unified India' model to enhance agility and speed in decision-making.
Key Highlights
Underlying Volume Growth (UVG) stood at 4% and Underlying Sales Growth (USG) at 5% for the quarter.
Reported PAT rose 121% YoY to ₹6,603 Cr, driven by portfolio transformation and the Ice Cream demerger.
Home Care segment achieved its highest-ever market share, with liquids delivering double-digit growth.
EBITDA margin contracted by 70 bps YoY to 23.3%, while EBITDA grew 3% to ₹3,788 Cr.
Board approved acquiring the remaining 49% stake in OZiva and divesting a 19.8% stake in Nutritionalab Pvt. Ltd.
👀 What to Watch
Investors should monitor the impact of the 'Unified India' restructuring on execution speed and the sustainability of volume growth in a dynamic commodity environment. The stock remains a defensive core holding, though margin pressure suggests a balanced near-term outlook.
HUL to Acquire Remaining 49% Stake in OZiva for ₹824 Cr; Divests Nutritionalab Stake for ₹307 Cr
Hindustan Unilever (HUL) has announced the full acquisition of Zywie Ventures (OZiva) by purchasing the remaining 49% stake for ₹824 crores, making it a wholly-owned subsidiary. Simultaneously, the company is divesting its 19.8% minority stake in Nutritionalab to USV Private Limited for ₹307 crores. These moves align with HUL's strategy to focus on high-growth 'bigger bets' within the Health & Wellbeing segment. OZiva has demonstrated strong performance, scaling to a projected ₹480 crores in 2025 with a 130% CAGR over the last two years.
Key Highlights
Acquisition of balance 49% stake in Zywie Ventures (OZiva) for a cash consideration of ₹824 crores.
Divestment of 19.8% stake in Nutritionalab for ₹307 crores to USV Private Limited.
OZiva's turnover grew significantly from ₹100.07 crores in FY23 to ₹257.67 crores in FY25.
Both transactions are expected to be completed by March 31, 2026, subject to closing conditions.
Post-transaction, OZiva and its subsidiary Zenherb Labs will become wholly-owned subsidiaries of HUL.
👀 What to Watch
Investors should view this as a positive consolidation move that streamlines HUL's Health & Wellbeing portfolio into high-growth brands. Monitor the integration of OZiva and its contribution to HUL's overall margin profile in the coming quarters.
HUL to Acquire Remaining 49% Stake in OZiva for ₹824 Cr; Divests Nutritionalab Stake for ₹307 Cr
Hindustan Unilever (HUL) has approved the acquisition of the remaining 49% stake in Zywie Ventures (OZiva) for ₹824 Crores, making it a wholly-owned subsidiary. Simultaneously, the company is divesting its 19.8% minority stake in Nutritionalab to USV Private Limited for ₹307 Crores. This move aligns with HUL's strategy to focus on fewer, bigger bets within the fast-growing Health & Wellbeing segment. OZiva has shown significant growth, with its turnover rising from ₹100.07 Crores in FY23 to ₹257.67 Crores in FY25.
Key Highlights
Acquisition of 49% balance stake in Zywie Ventures (OZiva) for a cash consideration of ₹824 Crores
Divestment of 19.8% stake in Nutritionalab to USV Private Limited for ₹307 Crores
OZiva's turnover grew significantly from ₹100.07 Crores in FY23 to ₹257.67 Crores in FY25
Both transactions are expected to be completed by March 31, 2026
Post-acquisition, Zywie and its subsidiary Zenherb Labs will become 100% subsidiaries of HUL
👀 What to Watch
Investors should view this as a positive strategic consolidation in the high-margin health and wellness space. Monitor the integration of OZiva and its impact on HUL's non-traditional FMCG margins over the next few quarters.
